Atlas Trials

TOFAcitinib in SARS-CoV2 Pneumonia

Clinical trial NCT04332042 · UNKNOWN

Trial details

NCT number
NCT04332042
Sponsor
Università Politecnica delle Marche
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
SARS-COv2 Related Interstitial Pneumonia
Start date
2020-04-10
Primary completion
2020-06-20
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.